{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:54:19Z","timestamp":1791338059695,"version":"4.3.1"},"reference-count":73,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00005-017-0458-6","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T20:09:46Z","timestamp":1489608586000},"page":"325-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effects of IFN-\u03b21a and IFN-\u03b21b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis"],"prefix":"10.2478","volume":"65","author":[{"given":"Natalia","family":"Lubina-D\u0105browska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Stepie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"D\u0105browska-Bouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zef","family":"Langfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Chalimoniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"key":"458_CR1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi A, Barres BA, Bennett ML (2013) Microglia scapegoat, saboteur, or something else? Science 339:156\u2013161","journal-title":"Science"},{"key":"458_CR2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaut.2011.06.003","volume":"37","author":"R Aharoni","year":"2011","unstructured":"Aharoni R, Vainshtein A, Stock A et al (2011) Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. J Autoimmun 37:228\u2013241","journal-title":"J Autoimmun"},{"key":"458_CR3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/10799900260475696","volume":"22","author":"F Antonetti","year":"2002","unstructured":"Antonetti F, Finocchiaro O, Mascia M et al (2002) A comparison of the biologic activity of two recombinant IFN-preparations used in the treatment of relapsing-remitting multiple sclerosis. J Interferon Cytokine Res 22:1181\u20131184","journal-title":"J Interferon Cytokine Res"},{"key":"458_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02540959","volume":"15","author":"T Asakawa","year":"1980","unstructured":"Asakawa T, Matsushita S (1980) Coloring conditions of thiobarbituric acid test for detecting lipid hydroperoxides. Lipids 15:137\u2013140","journal-title":"Lipids"},{"key":"458_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0079-6123(08)61151-6","volume":"103","author":"JS Beckman","year":"1994","unstructured":"Beckman JS, Chen J, Crow JP et al (1994) Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 103:371\u2013380","journal-title":"Prog Brain Res"},{"key":"458_CR6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.10.006","volume":"45","author":"K Bendfeldt","year":"2009","unstructured":"Bendfeldt K, Kuster P, Traud S et al (2009) Association of regional gray matter volume loss and progression of white matter lession in multiple sclerosis\u2014alongitudinal voxel based morphometry study. Neuroimage 45:60\u201367","journal-title":"Neuroimage"},{"key":"458_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.035","volume":"1325","author":"K Bendfeldt","year":"2010","unstructured":"Bendfeldt K, Egger H, Nichols TE et al (2010) Effect of immunomodulatory medication on regional gray matter loss in replasing-remitting multiple sclerosis\u2014a longitudinal MRI study. Brain Res 1325:174\u2013182","journal-title":"Brain Res"},{"key":"458_CR8","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.4049\/jimmunol.158.6.2940","volume":"158","author":"T Brenner","year":"1997","unstructured":"Brenner T, Brocke S, Szafer F et al (1997) Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J Immunol 158:2940\u20132946","journal-title":"J Immunol"},{"key":"458_CR9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1750-3639.1996.tb00853.x","volume":"6","author":"CF Brosnan","year":"1996","unstructured":"Brosnan CF, Raine CS (1996) Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243\u2013257","journal-title":"Brain Pathol"},{"key":"458_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jnr.10408","volume":"70","author":"V Calabrese","year":"2002","unstructured":"Calabrese V, Scapagnini G, Ravagna A et al (2002) Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 70:580\u2013587","journal-title":"J Neurosci Res"},{"key":"458_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00019052-200006000-00001","volume":"13","author":"G Comi","year":"2000","unstructured":"Comi G (2000) Why treat early multiple sclerosis patiens? Curr Opin Neurol 13:235\u2013240","journal-title":"Curr Opin Neurol"},{"key":"458_CR12","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","volume":"357","author":"G Comi","year":"2001","unstructured":"Comi G, Filippi M, Barkhof F et al (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. The Lancet 357:1576\u20131582","journal-title":"The Lancet"},{"key":"458_CR13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Muliple sclerosis. The Lancet 372:1502\u20131517","journal-title":"The Lancet"},{"key":"458_CR14","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI117282","volume":"93","author":"AH Cross","year":"1994","unstructured":"Cross AH, Misko TP, Lin RF et al (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 93:2684\u20132690","journal-title":"J Clin Invest"},{"key":"458_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2005.11.022","volume":"173","author":"AH Cross","year":"2006","unstructured":"Cross AH, Ramsbottom MJ, Lyons JA (2006) NOS 2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis. J Neuroimmunol 173:79\u201386","journal-title":"J Neuroimmunol"},{"key":"458_CR16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2174\/092986707780597961","volume":"14","author":"ST Dheen","year":"2007","unstructured":"Dheen ST, Kaur C, Ling EA (2007) Microlgila activation and its implications in the brain diseases. Curr Med Chem 14:1189\u20131197","journal-title":"Curr Med Chem"},{"key":"458_CR17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","volume":"352","author":"European Study Group on Interferon \u03b2-1b in Secondary Progressive MS","year":"1998","unstructured":"European Study Group on Interferon \u03b2-1b in Secondary Progressive MS (1998) Placebo controlled multicentre randomised trial of interferon \u03b2-1b in treatment of secondary progressive multiple sclerosis. European Study Group on Interferon \u03b2-1b in Secondary Progressive MS. The Lancet 352:1491\u20131497","journal-title":"The Lancet"},{"key":"458_CR18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.57.8.1357","volume":"57","author":"G Giovannoni","year":"2001","unstructured":"Giovannoni G, Thorpe J (2001) Is it multiple sclerosis or not? Neurology 57:1357\u20131358","journal-title":"Neurology"},{"key":"458_CR19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-510X(96)00246-8","volume":"145","author":"G Giovannoni","year":"1997","unstructured":"Giovannoni G, Heales SJ, Silver NC et al (1997) Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J Neurol Sci 145:77\u201381","journal-title":"J Neurol Sci"},{"key":"458_CR20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2007.01.011","volume":"185","author":"JJ Graber","year":"2007","unstructured":"Graber JJ, Ford D, Zhan M et al (2007) Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response. J Neuroimmunol 185:168\u2013174","journal-title":"J Neuroimmunol"},{"key":"458_CR21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1191\/0269215503cr688oa","volume":"17","author":"MJ Groom","year":"2003","unstructured":"Groom MJ, Lincoln NB, Francis VM et al (2003) Assessing mood in patients with multiple sclerosis. Clin Rehabil 17:847\u2013857","journal-title":"Clin Rehabil"},{"key":"458_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(97)00172-0","volume":"82","author":"P Guthikonda","year":"1998","unstructured":"Guthikonda P, Baker J, Mattson DH (1998) Interferon-beta 1b decreases induced nitric oxide production by human astrocytoma cell line. J Neuroimmunol 82:133\u2013139","journal-title":"J Neuroimmunol"},{"issue":"suppl 6","key":"458_CR23","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.45.6_Suppl_6.S22","volume":"45","author":"HP Hartung","year":"1995","unstructured":"Hartung HP, Archelos JJ, Zielasek J et al (1995) Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 45(suppl 6):S22\u2013S32","journal-title":"Neurology"},{"key":"458_CR24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.freeradbiomed.2009.07.013","volume":"47","author":"T Hoang","year":"2009","unstructured":"Hoang T, Choi DK, Nagai M et al (2009) Neuronal NOS and cykoloxygenase\u20142 contribute to DNA-damage in a mouse model of Parkinson disease. Free Radic Biol Med 47:1049\u20131056","journal-title":"Free Radic Biol Med"},{"key":"458_CR25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4049\/jimmunol.164.2.1103","volume":"164","author":"A Holz","year":"2000","unstructured":"Holz A, Bielekova B, Martin R et al (2000) Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J Immunol 164:1103\u20131109","journal-title":"J Immunol"},{"key":"458_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pharmthera.2004.11.007","volume":"106","author":"J Imitola","year":"2005","unstructured":"Imitola J, Chitnis T, Khoury SJ (2005) Cytokine in multiple sclerosis: from bench to bedside. Pharmacol Ther 106:167\u2013177","journal-title":"Pharmacol Ther"},{"key":"458_CR27","first-page":"423971","volume":"2011","author":"S Ireland","year":"2011","unstructured":"Ireland S, Monson N (2011) Potential impact of B cells and T cell function in multiple sclerosis. Mult Scler Int 2011:423971","journal-title":"Mult Scler Int"},{"key":"458_CR28","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"KP Johnson","year":"1995","unstructured":"Johnson KP, Brooks BR, Cohen JA et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebocontrolled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology 45:1268\u20131276","journal-title":"Neurology"},{"key":"458_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jnr.10649","volume":"73","author":"KG Kahl","year":"2003","unstructured":"Kahl KG, Zielasek J, Uttenthal LO et al (2003) Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res 73:198\u2013205","journal-title":"J Neurosci Res"},{"issue":"6","key":"458_CR30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/brain\/awh156","volume":"127","author":"JR Kanwar","year":"2004","unstructured":"Kanwar JR, Kanwar RK, Krissansen GW (2004) Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 127(Pt 6):1313\u20131331","journal-title":"Brain"},{"key":"458_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2011.08.008","volume":"95","author":"M Kapadia","year":"2011","unstructured":"Kapadia M, Sakic B (2011) Autoimmune and inflammatory mechanisms of CNS damage. Prog Neurobiol 95:301\u2013333","journal-title":"Prog Neurobiol"},{"key":"458_CR32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0002-9440(10)63232-4","volume":"164","author":"M Kerschensteiner","year":"2004","unstructured":"Kerschensteiner M, Stadelmann C, Buddeberg BS et al (2004) Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol 164:1455\u20131469","journal-title":"Am J Pathol"},{"key":"458_CR33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"UK Laemmli","year":"1970","unstructured":"Laemmli UK (1970) Cleavage of structural proteins during the assembly of the heat of bacteriophage T4. Nature 227:680\u2013685","journal-title":"Nature"},{"key":"458_CR34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/icb.2009.111","volume":"88","author":"Y Liu","year":"2010","unstructured":"Liu Y, Teige I, Ericsson I et al (2010) Suppression of EAE by oral tolerance is independent of endogenous IFN-beta whereas treatment with recombinant IFN-beta ameliorates EAE. Immunol Cell Biol 88:468\u2013476","journal-title":"Immunol Cell Biol"},{"key":"458_CR35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/1351000211Y.0000000007","volume":"16","author":"S Ljubisavljevic","year":"2011","unstructured":"Ljubisavljevic S, Stojanovic I, Pavlovic D et al (2011) Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains. Redox Rep 16:166\u2013172","journal-title":"Redox Rep"},{"key":"458_CR36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Br\u00fcck W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"458_CR37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/13550280802093927","volume":"14","author":"CP Marques","year":"2008","unstructured":"Marques CP, Cheeran MC, Palmquist JM et al (2008) Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis. J Neurovirol 14:229\u2013238","journal-title":"J Neurovirol"},{"key":"458_CR38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0166-2236(96)10047-3","volume":"19","author":"JE Merrill","year":"1996","unstructured":"Merrill JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 19:331\u2013338","journal-title":"Trends Neurosci"},{"key":"458_CR39","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1523\/JNEUROSCI.21-16-06214.2001","volume":"21","author":"R Meyer","year":"2001","unstructured":"Meyer R, Weissert R, Diem R et al (2001) Acute neuronal apoptosis in a rat model of multiple sclerosis. J Neurosci 21:6214\u20136220","journal-title":"J Neurosci"},{"key":"458_CR40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.0953-816x.2000.01412.x","volume":"13","author":"E Molina-Holgado","year":"2001","unstructured":"Molina-Holgado E, Vela JM, Ar\u00e9valo-Mart\u00edn A et al (2001) LPS\/IFN-\u03b3 cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13:493\u2013502","journal-title":"Eur J Neurosci"},{"issue":"1","key":"458_CR41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/brain\/119.1.213","volume":"119","author":"V Navikas","year":"1996","unstructured":"Navikas V, He B, Link J et al (1996a) Augmented expression of tumor necrosis factor-\u03b1 and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 119(Pt 1):213\u2013223","journal-title":"Brain"},{"key":"458_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-5728(95)00155-7","volume":"64","author":"V Navikas","year":"1996","unstructured":"Navikas V, Matusevicius D, S\u00f6derstr\u00f6m M et al (1996b) Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 64:63\u201369","journal-title":"J Neuroimmunol"},{"key":"458_CR43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1054\/jocn.2001.1077","volume":"9","author":"B Nazliel","year":"2002","unstructured":"Nazliel B, Ta\u015fkiran D, Irkec C et al (2002) Serum nitric oxide metabolites in patients with multiple sclerosis. J Clin Neurosci 9:530\u2013532","journal-title":"J Clin Neurosci"},{"key":"458_CR44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cyto.2012.06.011","volume":"60","author":"AK Nunes","year":"2012","unstructured":"Nunes AK, Raposo C, Luna RL et al (2012) Sidnafil (Viagra) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model. Cytokine 60:540\u2013551","journal-title":"Cytokine"},{"key":"458_CR45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-5728(95)00114-H","volume":"62","author":"Y Okuda","year":"1995","unstructured":"Okuda Y, Nakatsuji Y, Fujimura H et al (1995) Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 62:103\u2013112","journal-title":"J Neuroimmunol"},{"key":"458_CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.niox.2010.04.007","volume":"23","author":"A Pautz","year":"2010","unstructured":"Pautz A, Art J, Hahn S et al (2010) Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 23:75\u201393","journal-title":"Nitric Oxide"},{"key":"458_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02740619","volume":"14","author":"B Popko","year":"1997","unstructured":"Popko B, Corbin JG, Baerwald KD et al (1997) The effects of interferon-\u03b3 on the central nervous system. Mol Neurobiol 14:19\u201335","journal-title":"Mol Neurobiol"},{"key":"458_CR48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-5728(91)90054-B","volume":"33","author":"RM Ransohoff","year":"1991","unstructured":"Ransohoff RM, Devajyothi C, Estes ML et al (1991) Interferon-\u03b2 specifically inhibits interferon-\u03b3-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J Neuroimmunol 33:103\u2013112","journal-title":"J Neuroimmunol"},{"key":"458_CR49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainresbull.2014.04.002","volume":"104","author":"C Raposo","year":"2014","unstructured":"Raposo C, Luna RL, Nunes AK et al (2014) Role of iNOS-NO-cGMP signaling in modulation of inflamamatory and myelination processes. Brain Res Bull 104:60\u201373","journal-title":"Brain Res Bull"},{"key":"458_CR50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.410370115","volume":"37","author":"P Rieckmann","year":"1995","unstructured":"Rieckmann P, Albrecht M, Kitze B et al (1995) Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37:82\u201388","journal-title":"Ann Neurol"},{"key":"458_CR51","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1517\/14656566.6.16.2877","volume":"6","author":"J R\u00edo","year":"2005","unstructured":"R\u00edo J, Montalban X (2005) Interferon-\u03b2 1b in the treatment of multiple sclerosis. Expert Opin Pharmacother 6:2877\u20132886","journal-title":"Expert Opin Pharmacother"},{"key":"458_CR52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1996.tb08304.x","volume":"103","author":"SR Ruuls","year":"1996","unstructured":"Ruuls SR, Van Der Linden S, Sontrop K et al (1996) Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin Exp Immunol 103:467\u2013474","journal-title":"Clin Exp Immunol"},{"key":"458_CR53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1191\/1352458503ms865oa","volume":"9","author":"HH Salama","year":"2003","unstructured":"Salama HH, Kolar OJ, Zang YC et al (2003) Effects of combination therapy of beta-interferon 1a and prednisone on serum immunologic markers in patients with multiple sclerosis. Mult Scler 9:28\u201331","journal-title":"Mult Scler"},{"key":"458_CR54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2009.05.015","volume":"213","author":"C Schneider","year":"2009","unstructured":"Schneider C, Schuetz G, Zollner TM (2009) Acute neuroinflammation in Lewis rats: a model for aute multiple sclerosisi relapses. J Neuroimmunol 213:84\u201390","journal-title":"J Neuroimmunol"},{"key":"458_CR55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410230405","volume":"23","author":"KW Selmaj","year":"1988","unstructured":"Selmaj KW, Rain CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339\u2013346","journal-title":"Ann Neurol"},{"key":"458_CR56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJM199108153250704","volume":"325","author":"MK Sharief","year":"1991","unstructured":"Sharief MK, Hentges R (1991) Association between tumor necrosis factor-\u03b1 and disease progression in patients with multiple sclerosis. N Engl J Med 325:467\u2013472","journal-title":"N Engl J Med"},{"key":"458_CR57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5115\/acb.2012.45.3.141","volume":"45","author":"T Shin","year":"2012","unstructured":"Shin T, Meejung A, Matsumoto Y (2012) Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights form macrophages. Anat Cell Biol 45:141\u2013148","journal-title":"Anat Cell Biol"},{"key":"458_CR58","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683\u2013747","journal-title":"Annu Rev Immunol"},{"key":"458_CR59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WCO.0b013e328346056f","volume":"24","author":"C Stadelmann","year":"2011","unstructured":"Stadelmann C (2011) Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 24:224\u2013229","journal-title":"Curr Opin Neurol"},{"key":"458_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000348701","volume":"20","author":"A St\u0119pie\u0144","year":"2013","unstructured":"St\u0119pie\u0144 A, Chalimoniuk M, Lubina-D\u0105browska N et al (2013) Effects of interferon \u03b2-1a and interferon \u03b2-1b monotherapies on selected serum cytokines an nitrite levels in patients with relapsing-remitting multiple sclerosis: a 3-year longitudinal study. Neuroimmunomodulation 20:213\u2013222","journal-title":"Neuroimmunomodulation"},{"key":"458_CR61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-5728(93)90178-2","volume":"45","author":"G Stoll","year":"1993","unstructured":"Stoll G, Jung S, Jander S et al (1993) Tumor necrosis factor-\u03b1 in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 45:175\u2013182","journal-title":"J Neuroimmunol"},{"key":"458_CR62","unstructured":"St\u00fcve O, Oksenberg J (2010) Multiple Sclerosis Overview. In: Pagon RA, Adam MP, Bird TD et al (eds) GeneReviews\u2122 [Internet]. University of Washington, Seattle (WA), 1993\u20132013"},{"key":"458_CR63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.05.006","volume":"261","author":"G Sulkowski","year":"2013","unstructured":"Sulkowski G, D\u0105browska-Bouta B, Chalimoniuk M et al (2013) Effects of antagonist of glutamamte receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis. J Neuroimmunol 261:67\u201376","journal-title":"J Neuroimmunol"},{"key":"458_CR64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0165-5728(96)00199-3","volume":"73","author":"N Tanuma","year":"1997","unstructured":"Tanuma N, Kojima T, Shin T et al (1997) Competitive PCR quantification of pro- and anti-inflammatory cytokine mRNA in the central nervous system during autoimmne encephalomyelitis. J Neuroimmunol 73:197\u2013206","journal-title":"J Neuroimmunol"},{"key":"458_CR65","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/01.WNL.0000154526.22878.30","volume":"64","author":"M Tiberio","year":"2005","unstructured":"Tiberio M, Chard DT, Altmann DR et al (2005) Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 64:1001\u20131007","journal-title":"Neurology"},{"key":"458_CR66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00019052-199906000-00008","volume":"12","author":"BD Trapp","year":"1999","unstructured":"Trapp BD, Ransohoff R, Rudick R (1999) Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 12:295\u2013302","journal-title":"Curr Opin Neurol"},{"key":"458_CR67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jneuroim.2003.09.012","volume":"145","author":"RC Veen Van der","year":"2003","unstructured":"Van der Veen RC, Dietlin TA, Hofman FM (2003) Tissue expression of inducible nitric oxide synthase requires IFN-gamma production by infiltrating splenic Tcells: more evidence for immunosuppression by nitric oxide. J Neuroimmunol 145:86\u201390","journal-title":"J Neuroimmunol"},{"issue":"suppl 1","key":"458_CR68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","volume":"255","author":"HL Weiner","year":"2008","unstructured":"Weiner HL (2008) A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis. J Neurol 255(suppl 1):3\u201311","journal-title":"J Neurol"},{"issue":"suppl 3","key":"458_CR69","doi-asserted-by":"crossref","first-page":"iii56","DOI":"10.1136\/ard.2008.098020","volume":"67","author":"H Wekerle","year":"2008","unstructured":"Wekerle H (2008) Lessons from multiple sclerosis: models concepts observations. Ann Rheum Dis 67(suppl 3):iii56\u2013i60","journal-title":"Ann Rheum Dis"},{"key":"458_CR70","first-page":"91","volume":"39","author":"M Wender","year":"2001","unstructured":"Wender M, Michalak S, Wygladalska-Jernas H (2001) The effect of short-term treatment with interferon beta 1a on acute experimental allergic encephalomyelitis. Folia Neuropathol 39:91\u201393","journal-title":"Folia Neuropathol"},{"key":"458_CR71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(99)00212-X","volume":"100","author":"DO Willenborg","year":"1999","unstructured":"Willenborg DO, Staykova MA, Cowden WB (1999) Our shifting understanding of the role of nitirc oxide i autoimmune encephalomyelitis: a review. J Neuroimmunol 100:21\u201335","journal-title":"J Neuroimmunol"},{"key":"458_CR72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0008-8749(92)90131-8","volume":"141","author":"J Zielasek","year":"1992","unstructured":"Zielasek J, Tausch M, Toyka KV et al (1992) Production of nitrite by neonatal rat microglial cells\/brain macrophages. Cell Immunol 141:111\u2013120","journal-title":"Cell Immunol"},{"key":"458_CR73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1352458506070446","volume":"13","author":"R Zivadinov","year":"2007","unstructured":"Zivadinov R, Locatelli L, Cookfair D et al (2007) Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. Mult Scler 13:490\u2013501","journal-title":"Mult Scler"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-017-0458-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-017-0458-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-017-0458-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:48:53Z","timestamp":1704228533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-017-0458-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["458"],"URL":"https:\/\/doi.org\/10.1007\/s00005-017-0458-6","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}